PE-22-28 Nasal Spray in Thailand: Antidepressant & Cognitive Therapy
PE-22-28 is an intranasal neuropeptide that targets TREK-1 potassium channels to produce antidepressant-like effects, supporting mood regulation, emotional resilience, and mental well-being. In physician-supervised protocols, it is used for mood support and treatment-resistant depression management.
Doctor-prescribed PE-22-28 Nasal Spray in Thailand is available at Peptides Thailand under physician supervision, with clinical-grade, COA-verified intranasal formulation. It is prescribed for mood and antidepressant support protocols, offering rapid CNS delivery and fast-onset effects through the intranasal route.
How PE-22-28 Nasal Spray Works
PE-22-28 operates through sophisticated pathways to influence mood and emotional processing. Its primary mechanism involves modulating neurotransmitter systems and neural pathways associated with mood regulation. The nasal delivery system ensures rapid absorption and enhanced bioavailability, allowing the peptide to effectively cross the blood-brain barrier and influence emotional processing centers in the brain.
Medical Review Status
Last reviewed: June 2026 | Next review: December 2026
Written by Dr. Michael Ackland · Medically reviewed by Dr. Ploy Pitayanon, MD, licensed by the Medical Council of Thailand
At a Glance
Peptide
PE-22-28 Nasal Spray
Category
Nasal Peptide
Dosage
400 mcg per spray
Frequency
1 spray in each nostril once daily
Administration
Intranasal spray
Potential Benefits
- · Supports emotional well-being
- · Helps regulate mood
- · Enhances stress resilience
Quality Matters
Why we use Clinical-Grade only
Certificate of Analysis
Every peptide we dispense comes with a third-party COA confirming purity and potency, never grey-market sourced.
Compounded in Thailand
Manufactured in Thai FDA-licensed compounding laboratories operating under GMP standards.
Physician-prescribed only
No dispensing without a prescription. Every protocol begins with a licensed physician consultation and clinical assessment.
Medical Disclaimer
The information on this page is intended for educational and informational purposes only and should not be considered medical advice, diagnosis, or treatment. Any therapies, consultations, or prescriptions are provided only following assessment by a licensed physician and where clinically appropriate. Individual results may vary and no specific outcomes are guaranteed. Certain compounds discussed may not be approved medicines registered with the Thai FDA for specific therapeutic indications. Nothing here should be interpreted as a recommendation to self diagnose, self treat, or replace consultation with a qualified healthcare professional.
Doctor's Note
Dr. Ploy Pitayanon, MD, Medical Lead
PE-22-28 Nasal Spray requires careful medical supervision and individualized dosing. Our clinics in Chiang Mai and Phuket provide comprehensive assessment, monitoring, and ongoing support to ensure safe and effective treatment outcomes.
Potential Benefits
Supports emotional well-being
Helps regulate mood
Enhances stress resilience
Improves emotional balance
Supports mental clarity
Promotes positive outlook
Reduces emotional volatility
Enhances cognitive stability
Supports overall mental health
Improves stress response
Speak with a physician
Interested in PE-22-28 Nasal Spray?
All protocols require a physician assessment before any prescription is issued. Book a free video consultation with an MCT-licensed doctor.
Treatment Protocol
Dosage
400 mcg per spray
Frequency
1 spray in each nostril once daily
Duration
4-8 weeks per cycle
Administration
Intranasal spray
Safety guide
PE-22-28 Nasal Spray Side Effects & Safety
Frequency, contraindications, and who is a good candidate
Recent PE-22-28 Nasal Spray Research
Truncated TrkB: The Predominant TrkB Isoform in Nociceptors and Its Role in Pain Modulation
Characterised TrkB receptor isoforms in sensory neurons, providing mechanistic context for how TrkB-targeting peptides including PE-22-28 modulate mood and pain pathways via BDNF receptor activation (J Pain, 2025).
View on PubMedAntidepressant-Like Effect and Mechanism of Action of Honokiol on LPS-Induced Depression in Mice
Demonstrated antidepressant effects mediated via TrkB/BDNF upregulation and neuroinflammation reduction, describing a pathway directly relevant to the mechanism of PE-22-28 as a TrkB partial agonist (Molecules, 2019).
View on PubMedImpact of Relapse on BDNF Receptor Expression in Patients with a First Episode of Schizophrenia
Showed BDNF receptor expression changes correlate with neuropsychiatric symptom severity, underscoring TrkB signalling as a key pathway for mood and cognition modulation targeted by PE-22-28 (Schizophr Bull, 2025).
View on PubMedRelated Peptides
Prefer to message first?
Chat with our team on WhatsApp. We typically reply within minutes.
Chat about PE-22-28 Nasal Spray